Supernus Pharmaceuticals | SUPN - Trade Creditors


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Supernus Pharmaceuticals

Supernus Pharmaceuticals reported $11.54M in Trade Creditors for its fiscal quarter ending in March of 2023.


Trade Creditors Change
Abbott ABT:US USD 4.17B 440M
ANI Pharmaceuticals ANIP:US USD 32.69M 3.38M
Cara Therapeutics CARA:US USD 4.42M 5.18M
Corcept Therapeutics CORT:US USD 11.22M 760K
Eisai 4523:JP JPY 86.83B 17.96B
Eli Lilly LLY:US USD 2.02B 85.3M
Endo International ENDP:US USD 96.75M 12.28M
Horizon Pharma HZNP:US USD 76.62M 79.18M
Marinus Pharmaceuticals MRNS:US USD 4.47M 5K
Pacira PCRX:US USD 17.26M 2.04M
Perrigo PRGO:US USD 505.2M 32.1M
Revance Therapeutics RVNC:US USD 13M 8.45M
Supernus Pharmaceuticals SUPN:US USD 11.54M 1M
Xeris Pharmaceuticals Inc XERS:US USD 11.98M 7.38M